Aurinia Pharmaceuticals (AUPH) Misses Q2 EPS by 2c

August 6, 2019 4:46 PM

Aurinia Pharmaceuticals (NASDAQ: AUPH) reported Q2 EPS of ($0.17), $0.02 worse than the analyst estimate of ($0.15). Revenue for the ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found